CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Income Statement
NASDAQ:CRBP - Nasdaq - US21833P3010 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 880.00K | 3.94M | 36.14M | |||
| Operating Expenses | 45.08M | 34.84M | 56.87M | 126.75M | 113.25M | |||
| Research and Development | 31.17M | 16.14M | 36.45M | 98.27M | 89.60M | |||
| Selling, General, and Administrative Expenses | 13.91M | 18.70M | 20.43M | 28.48M | 23.64M | |||
| Operating Income | -45.08M | -34.84M | -55.99M | -122.81M | -77.10M | |||
| Interest Income/Expense | -2.92M | -2.46M | -1.55M | -1.73M | 1.07M | |||
| Other Income/Expense | 3.39M | -50.00K | 11.90M | 13.27M | 4.58M | |||
| Non Recurring Items | 0.00 | -5.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -44.60M | -42.35M | -45.64M | -111.27M | -71.45M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -44.60M | -42.35M | -45.64M | -111.27M | -71.45M | |||
| EBITDA | -44.44M | -34.08M | -54.99M | -121.69M | -76.36M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.31 | -10.15 | -11.13 | -42.79 | -33.55 | |||
| Non GAAP EPS | -10.15 | -10.41 | -7.64 | -1.47 | -1.13 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -5186.36% | -2824.11% | -197.70% | |||
| Operating Profit Margin | N/A | N/A | -6362.50% | -3117.01% | -213.34% | |||
All data in USD